Asco 2026
A page on meetings in our medical research coverage, part of our health reporting, alongside the 3 reports filed on it so far.
T Cell Therapy Treats Atopic Dermatitis
A Lancet comment published August 21, 2026, discusses rezpegaldesleukin, a novel therapy designed to expand regulatory T cells for treating
Lancet warns of new biosecurity risks
A Lancet editorial published on August 29, 2026, argues that political focus on COVID-19 origins is hindering preparedness for emerging biosecurity...
UK feasibility trial finds psilocybin therapy safe for resistant depression
A 2026 feasibility study delivering psilocybin-assisted therapy within the NHS reported high adherence and no safety concerns, raising questions...